NIV Settings for ARDS
Noninvasive ventilation should generally NOT be used routinely in ARDS, but if attempted in carefully selected mild ARDS patients with close monitoring, use CPAP or NIV with settings that maintain lung-protective principles: PEEP ≥5 cmH₂O, target SpO₂ 92-97%, and ensure tidal volumes remain ≤8 mL/kg predicted body weight if using pressure support. 1
Critical Context: NIV is NOT Standard Care for ARDS
The major guidelines make no recommendation regarding routine NIV use in ARDS 1. This absence of endorsement is deliberate and important—NIV carries significant risks in this population.
When NIV Might Be Considered
NIV may be reasonable only in less severely ill patients with mild ARDS (PaO₂/FiO₂ 200-300 mmHg) under specific conditions 2:
- Hemodynamically stable patients
- ICU setting with highly skilled staff
- Capacity for continuous close monitoring
- Immediate availability of intubation
Evidence Against NIV in ARDS
The data reveal concerning patterns:
- NIV failure rates increase with ARDS severity: 22.2% in mild, 42.3% in moderate, and 47.1% in severe ARDS 3
- Hospital mortality: 16.1% with NIV success vs. 45.4% with NIV failure 3
- Higher ICU mortality associated with NIV use, particularly in patients with PaO₂/FiO₂ <150 mmHg 3
- Delayed intubation from failed NIV trials worsens outcomes 4, 5
Specific NIV Settings (If Attempted)
Interface Selection
- Helmet interface preferred over face mask when available—associated with better outcomes in hypoxemic respiratory failure 6
- Face masks (oronasal or total face mask) are alternatives 7
Pressure Settings
PEEP/CPAP:
- Minimum 5 cmH₂O (required by Berlin ARDS definition) 2
- Consider higher PEEP (8-10 cmH₂O) in moderate-severe cases, titrated to oxygenation 2
Pressure Support (if using NIV rather than CPAP):
- Titrate to achieve tidal volumes ≤8 mL/kg predicted body weight 8
- Avoid excessive pressure support that generates large tidal volumes
- Monitor for patient-ventilator asynchrony
Oxygenation Targets
- SpO₂ 92-97% or PaO₂ 70-90 mmHg 2
- Titrate FiO₂ to achieve these targets while minimizing oxygen toxicity
Monitoring Parameters
Continuous assessment is mandatory:
- Respiratory rate and work of breathing
- Tidal volume monitoring (if available)
- Oxygenation trends
- Mental status changes
- Hemodynamic stability
Criteria for NIV Failure and Intubation
Intubate promptly if ANY of the following occur:
- Worsening oxygenation despite optimization
- Increasing respiratory rate or work of breathing
- Altered mental status or inability to protect airway
- Hemodynamic instability
- Patient intolerance of interface
- No improvement within 1-2 hours of NIV initiation 4, 5
Alternative: High-Flow Nasal Oxygen
Before attempting NIV, consider high-flow nasal cannula (HFNC) as initial noninvasive support 2, 7:
- May be safer than NIV in hypoxemic respiratory failure
- Provides PEEP effect (2-5 cmH₂O)
- Better tolerated than NIV interfaces
- Allows eating, drinking, and communication
Common Pitfalls to Avoid
- Using NIV in moderate-severe ARDS (PaO₂/FiO₂ <200 mmHg)—high failure rate and potential harm
- Delaying intubation when NIV is failing—significantly increases mortality
- Allowing large tidal volumes during NIV—perpetuates lung injury
- Inadequate monitoring—NIV requires ICU-level observation
- Using NIV in hemodynamically unstable patients—contraindicated
The Bottom Line
Most ARDS patients should proceed directly to invasive mechanical ventilation with lung-protective settings (tidal volume 4-8 mL/kg, plateau pressure ≤30 cmH₂O, appropriate PEEP) 1, 8, 1, 8. NIV is a high-risk strategy in ARDS that should be reserved for exceptional circumstances in mild disease with expert monitoring and low threshold for intubation.